, Déclaration sur la deuxième réunion du Comité d'urgence du Règlement sanitaire international, 2005.
Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy, Am J Obstet Gynecol, 2020. ,
Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know, Am J Obstet Gynecol, 2020. ,
Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections, Viruses. 2020, vol.10, issue.2 ,
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States, JAMA, vol.303, issue.15, pp.1517-1542, 2010. ,
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.128, p.104447, 2020. ,
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records, Lancet Lond Engl, vol.395, pp.809-824, 10226. ,
An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes, Arch Pathol Lab Med, 2020. ,
,
, Zhonghua Bing Li Xue Za Zhi, vol.49, issue.5, pp.418-441, 2020.
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn, JAMA, 2020. ,
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia, JAMA, 2020. ,
Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed, JAMA, 2020. ,
Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr, 2020. ,
,
, Gynecol Obstet Fertil Senol, 2020.
Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia, J Med Virol, 2020. ,
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review, JAMA, 2020. ,
, Covid-19 , Démarrage de l'essai clinique Discovery, 2020.
Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients ,
Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11), PLoS Med, vol.11, issue.4, p.1001635, 2014. ,
Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland, BMC Infect Dis, vol.16, p.65, 2016. ,
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res, vol.178, p.104786, 2020. ,
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs, Internet]. Microbiology, 2020. ,
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication [Internet]. Microbiology, 2020. ,
Zika virus cell tropism in the developing human brain and inhibition by azithromycin, Proc Natl Acad Sci, vol.113, issue.50, pp.14408-14421, 201613. ,
Azithromycin Inhibits the Replication of Zika Virus, J Antivir Antiretrovir, p.2020, 2018. ,
Evaluation of Ebola Virus Inhibitors for Drug Repurposing, ACS Infect Dis, vol.1, issue.7, pp.317-343, 2015. ,
Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication, Clin Chem, vol.28, issue.5, pp.1148-52, 1982. ,
Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers, Br J Clin Pharmacol, vol.65, issue.5, pp.674-683, 2008. ,
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study, Lancet Infect Dis, vol.12, issue.5, pp.388-96, 2012. ,
Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature, J Rheumatol, vol.38, issue.12, pp.2504-2512, 2011. ,
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clin Infect Dis Off Publ Infect Dis Soc Am, 2009. ,
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov, vol.6, p.16, 2020. ,
Combating COVID-19 with Chloroquine, J Mol Cell Biol, 2020. ,
,
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, Epidemiology, 2020. ,
Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial, 2020. ,
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection, Med Mal Infect, 2020. ,
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19, N Engl J Med, 2020. ,
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial, 2020. ,
,
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study, 2009. ,
Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19, Emergency Medicine, 2020. ,
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet, 2020. ,
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, Travel Med Infect Dis, 2020. ,
, JORF n°0012 du 15 janvier 2020. Texte n°13. Arrêté du 13 janvier 2020 portant classement sur les listes des substances vénéneuses.rtf
Hydroxychloroquine retinopathyimplications of research advances for rheumatology care, Nat Rev Rheumatol, vol.14, issue.12, pp.693-703, 2018. ,
Hydroxychloroquine-induced Retinal Toxicity, J Rheumatol, vol.47, issue.4, p.632, 2020. ,
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature, Drug Saf, vol.41, issue.10, pp.919-950, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02336998
Evidence of transplacental passage of hydroxychloroquine in humans, Arthritis Rheum, vol.46, issue.4, pp.1123-1127, 2002. ,
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group, Arthritis Rheum, vol.48, issue.11, pp.3207-3218, 2003. ,
Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future, Drug Saf, vol.29, issue.10, pp.845-63, 2006. ,
Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy, Expert Opin Drug Saf, vol.10, issue.5, pp.705-719, 2011. ,
Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum, vol.50, pp.3057-3058, 2004. ,
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option, J Med Virol, 2020. ,
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat Commun, vol.11, issue.1, p.222, 2020. ,
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl J Med, 2020. ,
Prise en charge médicale des personnes vivants avec le VIH. Recommandations du groupe d'experts. Désir d'enfant et grossesse (mai 2018), p.52, 2018. ,
, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes, AIDS Lond Engl, vol.33, issue.2, pp.295-304, 201901.
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.57, issue.6, pp.891-902, 2013. ,
Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment, Antimicrob Agents Chemother, vol.59, issue.9, pp.5727-5762, 2015. ,
Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model, Am J Obstet Gynecol, vol.195, issue.1, pp.296-301, 2006. ,
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women, Curr HIV Res, vol.7, issue.6, pp.620-625, 2009. ,
Transplacental passage of protease inhibitors at delivery, AIDS Lond Engl, vol.16, issue.6, pp.889-93, 2002. ,
Reduced indinavir exposure during pregnancy, Br J Clin Pharmacol, vol.76, issue.3, pp.475-83, 2013. ,
Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model, Obstet Gynecol Int, p.726593, 2009. ,
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model, Antimicrob Agents Chemother, vol.58, issue.9, pp.5617-5637, 2014. ,
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention, N Engl J Med, vol.375, issue.18, pp.1726-1763, 201603. ,
Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy, J Infect Dis, vol.204, issue.4, pp.506-520, 2011. ,
Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers, JAMA, vol.306, issue.1, pp.70-78, 2011. ,
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir, Viruses, vol.11, issue.4, 201904. ,
Controlled Trial of Ebola Virus Disease Therapeutics, N Engl J Med, vol.12, issue.24, pp.2293-303, 2019. ,
Broadspectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses, Sci Transl Med, vol.9, issue.396, 201728. ,
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase, Antiviral Res, vol.169, p.104541, 2019. ,
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection, Proc Natl Acad Sci, vol.117, issue.12, pp.6771-6777, 2020. ,
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus, J Biol Chem, 2020. ,
Remdesivir for the Treatment of Covid-19 -Preliminary Report, N Engl J Med, 2020. ,
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet, vol.395, pp.1569-78, 2020. ,
Compassionate Use of Remdesivir for Patients with Severe Covid-19, N Engl J Med, 2020. ,
Assessment report on Medicinal products under development for the treatment of Ebola, 2016. ,
, Avis relatif à la prise en charge des cas confirmés d'infection au virus SARS-CoV-2, p.33, 2020.
, Avis relatif à la prise en charge des cas confirmés d'infection au virus SARS-CoV-2, vol.33, 2020.
Epidemiology, Pathogenesis, and Control of COVID-19, Viruses, vol.12, issue.4, 202027. ,
Lack of Antiviral Activity of Darunavir against SARS-CoV-2 [Internet]. Infectious Diseases (except HIV/AIDS), 2020. ,
Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population, J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, vol.30, issue.11, pp.1288-92, 2017. ,
Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants, Birth Defects Res, vol.111, issue.19, pp.1487-93, 201915. ,
Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus, Antiviral Res, vol.151, pp.97-104, 2018. ,
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses, Antiviral Res, vol.153, pp.85-94, 2018. ,
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase, Proc Jpn Acad Ser B Phys Biol Sci, vol.93, issue.7, pp.449-63, 2017. ,
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model, Antiviral Res, vol.105, pp.17-21, 2014. ,
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study, J Infect Dis, vol.220, issue.2, pp.195-202, 201919. ,
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus. Viruses, vol.10, 201803. ,
Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection, J Infect Dis, 2019. ,
Influenza virus polymerase inhibitors in clinical development, Curr Opin Infect Dis, vol.32, issue.2, pp.176-86, 2019. ,
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect Dis, vol.14, issue.11, pp.1090-1095, 2014. ,
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study, Clin Infect Dis Off Publ Infect Dis Soc Am, 2019. ,
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, Birt Defects Res A Clin Mol Teratol, vol.88, issue.7, pp.551-560, 2003. ,
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?, vol.54, pp.1348-60, 2012. ,
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus, Biochem Biophys Res Commun, vol.318, issue.3, pp.719-744, 2004. ,
,
, Vopr Virusol, vol.53, issue.4, pp.9-13, 2008.
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study, J Infect, 2020. ,
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, 2020. ,
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study, Lancet Infect Dis, 2020. ,
Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep, J Vet Pharmacol Ther, vol.31, issue.5, pp.406-420, 2008. ,
Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health, vol.8, pp.92-100, 2020. ,
, Highlights of prescribing information, FDA.pdf, AVONEX
Final results from the Betaseron (interferon ?-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events, BMJ Open, vol.4, issue.5, p.4536, 2014. ,
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry, J Neurol, 2020. ,
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure, Ther Adv Neurol Disord, vol.13, p.1756286420910310, 2020. ,
Experimental study of transplacental passage of alpha interferon by two assay techniques, Antimicrob Agents Chemother, vol.37, issue.6, pp.1232-1239, 1993. ,
,
, Therapie, vol.48, issue.1, pp.73-78, 1993.
Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage, Fetal Diagn Ther, vol.10, issue.1, pp.7-10, 1995. ,
Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases. Vox Sang, 2020. ,
Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus Trasfus Sangue, vol.14, pp.152-159, 2016. ,
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea, N Engl J Med, vol.374, issue.1, pp.33-42, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01252702
Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol, vol.24, issue.1, pp.44-50, 2005. ,
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection, Chest, 2020. ,
Placental transport of immunoglobulin G. Vaccine, vol.21, pp.3365-3374, 2003. ,
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin Immunopathol, vol.39, issue.5, pp.529-568, 2017. ,
Placental transfer of tocilizumab in a patient with rheumatoid arthritis, Rheumatol Oxf Engl, vol.58, issue.9, pp.1694-1699, 201901. ,
Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study, Rheumatology, vol.57, issue.8, pp.1499-501, 2018. ,
Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan, Mod Rheumatol, vol.26, issue.5, pp.667-71, 2016. ,
Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data, Semin Arthritis Rheum, vol.46, issue.2, pp.238-283, 2016. ,
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation, Ann Rheum Dis, vol.75, issue.5, pp.795-810, 2016. ,
International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatol Oxf Engl, vol.56, pp.2102-2110, 201701. ,
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis, Drugs, vol.77, issue.16, pp.1755-68, 2017. ,
Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study, BMC Neurol, vol.17, issue.1, p.17, 2017. ,
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure, Ther Adv Neurol Disord, vol.11, p.1756286418804760, 2018. ,
Baricitinib: A Review in Rheumatoid Arthritis, Drugs, vol.78, issue.7, pp.761-72, 2018. ,
Baricitinib exposure during pregnancy in rheumatoid arthritis, Ther Adv Musculoskelet Dis, vol.12, pp.1759720-19899296, 2020. ,
The use of biologics and small molecules in pregnant patients with rheumatic diseases, Expert Rev Clin Pharmacol, vol.11, issue.10, pp.987-98, 2018. ,
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease, Aliment Pharmacol Ther, vol.21, issue.6, pp.733-741, 2005. ,
Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.4, issue.10, pp.1255-1263, 2006. ,
Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31, J Crohns Colitis, vol.6, issue.3, pp.358-61, 2012. ,
Colchicine may not be effective in COVID-19 infection; it may even be harmful?, Clin Rheumatol, 2020. ,
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis, Autoimmun Rev, 2020. ,
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design, Hell J Cardiol HJC Hell Kardiologike Epitheorese, 2020. ,
Transplacental passage of colchicine in familial Mediterranean fever, J Rheumatol, vol.21, issue.2, p.383, 1994. ,
Use of colchicine in pregnancy: a systematic review and meta-analysis, Rheumatol Oxf Engl, vol.57, issue.2, pp.382-389, 2018. ,
Pregnancy outcome after in utero exposure to colchicine, Am J Obstet Gynecol, vol.203, issue.2, pp.144-145, 2010. ,
The placental transfer of betamethasone, Eur J Clin Pharmacol, vol.18, issue.3, pp.245-252, 1980. ,
Drug therapy of the fetus, J Clin Pharmacol, vol.33, issue.9, pp.780-789, 1993. ,
Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids, Rev Reprod, vol.2, issue.3, pp.129-161, 1997. ,
Prophylactic corticosteroids for preterm birth, Cochrane Database Syst Rev, issue.2, p.65, 2000. ,
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock, Anesth Analg, 2020. ,
Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus, Cell Mol Life Sci CMLS, vol.61, issue.21, pp.2738-2781, 2004. ,
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, N Engl J Med, 2020. ,
Angiotensin II receptor antagonist treatment during pregnancy, Birt Defects Res A Clin Mol Teratol, vol.73, issue.2, pp.123-153, 2005. ,
Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report, J Pediatr, vol.167, issue.4, pp.881-886, 2015. ,
Dysregulation of the placental renin-angiotensin system in human fetal growth restriction, Reprod Camb Engl, vol.158, issue.3, pp.237-282, 2019. ,
Clinical effect of mifepristone on patients with ovarian cancer in pregnancy, Pak J Pharm Sci, vol.32, issue.1, pp.421-427, 2019. ,
Gynecologic cancer in pregnancy, Gynecol Oncol, 2020. ,
Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature, J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther, vol.31, issue.10, pp.605-615, 2015. ,
Intravitreal bevacizumab during pregnancy. Retina Phila Pa, vol.30, pp.1405-1416, 2010. ,
A short history of thalidomide embryopathy, Teratology, vol.38, issue.3, pp.203-218, 1988. ,
The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies, N Engl J Med, vol.267, pp.1184-1192, 1962. ,
Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review, Taiwan J Obstet Gynecol, vol.57, issue.4, pp.588-93, 2018. ,
Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review, Arch Gynecol Obstet, vol.277, issue.1, pp.75-83, 2008. ,
Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia, Obstet Gynecol, vol.107, issue.5, pp.1012-1019, 2006. ,
Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study, Orphanet J Rare Dis, vol.14, issue.1, p.50, 201918. ,
Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort, J Acquir Immune Defic Syndr, vol.81, issue.1, pp.83-94, 1999. ,
URL : https://hal.archives-ouvertes.fr/inserm-02070249
Ethics of studies of drugs in pregnancy, Paediatr Drugs, vol.17, issue.1, pp.31-36, 2015. ,
Increasing the Participation of Pregnant Women in Clinical Trials, JAMA, vol.320, issue.20, pp.2077-2085, 201827. ,
The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications, Seizure, vol.15, issue.8, pp.563-70, 2006. ,
The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications, Philos Ethics Humanit Med PEHM, vol.14, issue.1, p.11, 201906. ,
Models for Placental Transfer Studies of Drugs: Clin Pharmacokinet, vol.28, pp.161-80, 1995. ,
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer, J Clin Pharmacol, vol.59, issue.1, pp.70-81, 2019. ,
Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model, AIDS Lond Engl, vol.32, issue.3, pp.321-326, 201828. ,
Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir, Eur J Obstet Gynecol Reprod Biol, vol.147, issue.2, pp.157-60, 2009. ,
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models, Br J Clin Pharmacol, vol.81, issue.4, pp.646-57, 2016. ,
Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes, Ann Rheum Dis, vol.77, issue.4, pp.500-509, 2018. ,
Oseltamivir in pregnancy and birth outcomes, BMC Infect Dis, vol.18, issue.1, p.519, 2018. ,
The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment, Drug Saf, vol.40, issue.12, pp.1205-1223, 2017. ,
Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model, Am J Obstet Gynecol, vol.219, issue.6, pp.619-620, 2018. ,
Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes, Fetal Diagn Ther, vol.41, issue.2, pp.81-89, 2017. ,
Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study, Trials, vol.19, issue.1, p.524, 2018. ,
The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis, PloS One, vol.14, issue.7, p.219732, 2019. ,